Acurx Pharmaceuticals (ACXP)
1.77
0.00 (0.00%)
Upcoming Events
Latest Headlines
Acurx Pharmaceuticals (NASDAQ: ACXP) Highlights FDA's New CDI Guidance That Could Accelerate Approval Path for Ibezapolstat
May 19, 2026 12:26 PM - StreetInsider
Form 424B3 Acurx Pharmaceuticals,
May 12, 2026 3:05 PM - SEC Filing
Form 424B3 Acurx Pharmaceuticals,
May 12, 2026 3:04 PM - SEC Filing
Acurx Pharmaceuticals (ACXP) Misses Q1 EPS by 62c
May 12, 2026 8:44 AM - StreetInsider
Acurx Pharmaceuticals, Inc. Reports First Quarter 2026 results and Provides Business Update
May 12, 2026 7:01 AM - PR NewsWire
Form EFFECT Acurx Pharmaceuticals,
May 12, 2026 6:07 AM - SEC Filing
Form EFFECT Acurx Pharmaceuticals,
May 12, 2026 6:07 AM - SEC Filing
Form 10-Q Acurx Pharmaceuticals, For: Mar 31
May 11, 2026 4:07 PM - SEC Filing
Acurx Pharmaceuticals (ACXP) files for 1.3M share offering by selling stockholders
May 4, 2026 4:13 PM - StreetInsider
Form S-1 Acurx Pharmaceuticals,
May 4, 2026 4:10 PM - SEC Filing
Form S-1 Acurx Pharmaceuticals,
May 4, 2026 4:09 PM - SEC Filing
Acurx Announces Scientific Poster Presentation of its DNA pol IIIC Inhibitors' Microbiome Evaluation at ESCMID Global 2026
May 4, 2026 8:00 AM - PR NewsWire
Form D Acurx Pharmaceuticals,
April 29, 2026 4:19 PM - SEC Filing
Acurx Pharmaceuticals to Present at the Alliance Global Partners (A.G.P) Healthcare Company Showcase
April 29, 2026 8:00 AM - PR NewsWire
Acurx Pharmaceuticals, Inc. To Present at The Market Movers Investor Summit
April 27, 2026 8:04 AM - StreetInsider
Form 4 Acurx Pharmaceuticals, For: Apr 20 Filed by: Sailer Carl
April 22, 2026 4:21 PM - SEC Filing
Form 4 Acurx Pharmaceuticals, For: Apr 20 Filed by: DEAN JACK H
April 22, 2026 4:21 PM - SEC Filing
Form 4 Acurx Pharmaceuticals, For: Apr 20 Filed by: Donohue James J.
April 22, 2026 4:20 PM - SEC Filing
Form 4 Acurx Pharmaceuticals, For: Apr 20 Filed by: HARRISON THOMAS L
April 22, 2026 4:20 PM - SEC Filing
Form 4 Acurx Pharmaceuticals, For: Apr 20 Filed by: Scodari Joseph C
April 22, 2026 4:20 PM - SEC Filing
Form 4 Acurx Pharmaceuticals, For: Apr 20 Filed by: DELUCCIA ROBERT J
April 22, 2026 4:20 PM - SEC Filing
Form 4 Acurx Pharmaceuticals, For: Apr 20 Filed by: LUCI DAVID P
April 22, 2026 4:18 PM - SEC Filing
Form 4 Acurx Pharmaceuticals, For: Apr 20 Filed by: Shawah Robert G.
April 22, 2026 4:17 PM - SEC Filing
Acurx Pharmaceuticals to Discuss First Quarter 2026 Financial Results on May 12, 2026 Conference Call and Provide Business Update
April 20, 2026 8:00 AM - PR NewsWire
New to The Street to Broadcast Tonight on Bloomberg at 6:30 PM EST - Show #744 Featuring Virtuix Holdings (NASDAQ:VTIX), Neonc Technologies Holdings (NASDAQ:NTHI), Medicus Pharma (NASDAQ:MDCX), YY Gro
April 18, 2026 10:00 AM - StreetInsider
Acurx Pharmaceuticals closes $2.5M offering with potential $4.6M more
April 16, 2026 4:01 PM - StreetInsider
Acurx Pharmaceuticals, Inc. Announces Closing of up to $7.1 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
April 16, 2026 4:01 PM - PR NewsWire
Form 8-K Acurx Pharmaceuticals, For: Apr 15
April 16, 2026 8:15 AM - SEC Filing
Form 424B5 Acurx Pharmaceuticals,
April 16, 2026 8:14 AM - SEC Filing
ACXP raises $2.5 million in direct offering with warrant potential
April 16, 2026 8:00 AM - StreetInsider
Acurx Pharmaceuticals raises $2.5 million in registered direct offering
April 16, 2026 8:00 AM - StreetInsider
Acurx Pharmaceuticals, Inc. Announces up to $7.1 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
April 16, 2026 8:00 AM - PR NewsWire
New to The Street Resigns Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) to Continue Long-Form Interview Series, Outdoor Media Campaigns and Accredited Investor Events
April 7, 2026 9:03 AM - StreetInsider
New to The Street Announces Episode 741 Airing Tonight on Bloomberg Television at 6:30 PM EST Featuring Canton Networks, Acme Markets, Virtuix Holdings (VTIX), HPB, Jonas & Redman, Acurx Pharmaceutica
April 4, 2026 10:05 AM - StreetInsider
Korean Patent Office Grants Acurx Pharmaceuticals New Patent for DNA Polymerase IIIC Inhibitors
March 30, 2026 7:01 AM - PR NewsWire
New to The Street Broadcasts Show #740 on Bloomberg Television at 6:30 PM EST Featuring Medicus (MDCX), Acme Markets- Canton Foundation, Alpha Ton Capital (ATON), and Virtuix Holdings (NASDAQ:VTIX)
March 28, 2026 11:00 AM - StreetInsider
Acurx Pharmaceuticals (ACXP) Misses Q4 EPS by 532c
March 13, 2026 7:46 AM - StreetInsider
Acurx Pharmaceuticals, Inc. Reports Full Year and Fourth Quarter Results and Provides Business Update
March 13, 2026 7:01 AM - PR NewsWire
Form S-8 Acurx Pharmaceuticals,
March 12, 2026 4:18 PM - SEC Filing
Form 10-K Acurx Pharmaceuticals, For: Dec 31
March 12, 2026 4:07 PM - SEC Filing
Form 8-K Acurx Pharmaceuticals, For: Mar 09
March 9, 2026 9:00 AM - SEC Filing
Acurx Announces New Ibezapolstat Clinical Trial Program in Patients with Recurrent CDI That Has the Potential to Shift the Paradigm of Treatment and Prevention of C. difficile Infection
March 9, 2026 8:01 AM - PR NewsWire
Full Article List
